NASDAQ:GBIO
Generation Bio Co. Stock Company Profile
$3.35
+0.180 (+5.68%)
At Close: May 06, 2024
Information
301 Binney Street
Cambridge MA 02142
617 655 7500
generationbio.com
Industry: Biotechnology
Sector: Healthcare
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
